Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 131

1.

Does aspirin or non-aspirin non-steroidal anti-inflammatory drug use prevent colorectal cancer in inflammatory bowel disease?

Burr NE, Hull MA, Subramanian V.

World J Gastroenterol. 2016 Apr 7;22(13):3679-86. doi: 10.3748/wjg.v22.i13.3679. Review.

2.
3.

Effect of aspirin and NSAIDs on risk and survival from colorectal cancer.

Din FV, Theodoratou E, Farrington SM, Tenesa A, Barnetson RA, Cetnarskyj R, Stark L, Porteous ME, Campbell H, Dunlop MG.

Gut. 2010 Dec;59(12):1670-9. doi: 10.1136/gut.2009.203000. Epub 2010 Sep 15. Review.

PMID:
20844293
4.

Mesalamine protects against colorectal cancer in inflammatory bowel disease.

Tang J, Sharif O, Pai C, Silverman AL.

Dig Dis Sci. 2010 Jun;55(6):1696-703. doi: 10.1007/s10620-009-0942-x. Epub 2009 Aug 25.

PMID:
19705280
5.

Chemoprevention of colorectal cancer: systematic review and economic evaluation.

Cooper K, Squires H, Carroll C, Papaioannou D, Booth A, Logan RF, Maguire C, Hind D, Tappenden P.

Health Technol Assess. 2010 Jun;14(32):1-206. doi: 10.3310/hta14320. Review.

6.

Risk of colorectal cancer in self-reported inflammatory bowel disease and modification of risk by statin and NSAID use.

Samadder NJ, Mukherjee B, Huang SC, Ahn J, Rennert HS, Greenson JK, Rennert G, Gruber SB.

Cancer. 2011 Apr 15;117(8):1640-8. doi: 10.1002/cncr.25731. Epub 2010 Nov 8.

7.

Inflammatory markers are associated with risk of colorectal cancer and chemopreventive response to anti-inflammatory drugs.

Chan AT, Ogino S, Giovannucci EL, Fuchs CS.

Gastroenterology. 2011 Mar;140(3):799-808, quiz e11. doi: 10.1053/j.gastro.2010.11.041. Epub 2010 Nov 27.

8.

Aspirin for the prevention of colorectal cancer.

Garcia-Albeniz X, Chan AT.

Best Pract Res Clin Gastroenterol. 2011 Aug;25(4-5):461-72. doi: 10.1016/j.bpg.2011.10.015. Review.

9.

Patients' knowledge and fear of colorectal cancer risk in inflammatory bowel disease.

Lopez A, Collet-Fenetrier B, Belle A, Peyrin-Biroulet L.

J Dig Dis. 2016 Jun;17(6):383-91. doi: 10.1111/1751-2980.12356.

PMID:
27129893
10.

Aspirin as a chemoprevention agent for colorectal cancer.

Lee CS, McNamara D, O'Morain CA.

Curr Drug Metab. 2012 Nov;13(9):1313-22. Review.

PMID:
22493984
11.

Aspirin and nonsteroidal anti-inflammatory drug use and the risk of subsequent colorectal cancer.

Peleg II, Maibach HT, Brown SH, Wilcox CM.

Arch Intern Med. 1994 Feb 28;154(4):394-9.

PMID:
8117171
12.

Effects of non-steroidal anti-inflammatory drugs on cancer sites other than the colon and rectum: a meta-analysis.

González-Pérez A, García Rodríguez LA, López-Ridaura R.

BMC Cancer. 2003 Oct 31;3:28.

13.

Aminosalicylates and colorectal cancer in IBD: a not-so bitter pill to swallow.

Ryan BM, Russel MG, Langholz E, Stockbrugger RW.

Am J Gastroenterol. 2003 Aug;98(8):1682-7. Review.

PMID:
12907319
14.

Systematic review: interactions between aspirin, and other nonsteroidal anti-inflammatory drugs, and polymorphisms in relation to colorectal cancer.

Andersen V, Vogel U.

Aliment Pharmacol Ther. 2014 Jul;40(2):147-59. doi: 10.1111/apt.12807. Epub 2014 May 28. Review.

15.

Colorectal cancer in inflammatory bowel disease: the risk, pathogenesis, prevention and diagnosis.

Kim ER, Chang DK.

World J Gastroenterol. 2014 Aug 7;20(29):9872-81. doi: 10.3748/wjg.v20.i29.9872. Review.

16.

Chemoprevention: risk reduction with medical therapy of inflammatory bowel disease.

Chan EP, Lichtenstein GR.

Gastroenterol Clin North Am. 2006 Sep;35(3):675-712. Review.

PMID:
16952746
17.

Chemoprevention for colon cancer: new opportunities, fact or fiction?

Terhaar Sive Droste JS, Tuynman JB, Van Dullemen HM, Mulder CJ.

Scand J Gastroenterol Suppl. 2006;(243):158-64. Review.

PMID:
16782636
18.

5-Aminosalicylate use and colorectal cancer risk in inflammatory bowel disease: a large epidemiological study.

van Staa TP, Card T, Logan RF, Leufkens HG.

Gut. 2005 Nov;54(11):1573-8. Epub 2005 Jun 30. Review.

19.

Association between thiopurine use and nonmelanoma skin cancers in patients with inflammatory bowel disease: a meta-analysis.

Ariyaratnam J, Subramanian V.

Am J Gastroenterol. 2014 Feb;109(2):163-9. doi: 10.1038/ajg.2013.451. Epub 2014 Jan 14. Review.

PMID:
24419479
20.

Effect of aspirin and other non-steroidal anti-inflammatory drugs on prostate cancer incidence and mortality: a systematic review and meta-analysis.

Liu Y, Chen JQ, Xie L, Wang J, Li T, He Y, Gao Y, Qin X, Li S.

BMC Med. 2014 Mar 28;12:55. doi: 10.1186/1741-7015-12-55. Review.

Supplemental Content

Support Center